August 23, 2022
RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc., (OTCPINK: FZMD), (“Fuse” or the “Firm”) an rising producer and distributor of modern medical gadgets for the orthopedic and spine market, introduced that it has been ranked quantity 149 on the 2022 record of Dallas-Fort Value’s 150 largest public firms, by the Dallas Morning Information.
Fuse Medical’s 2021 income of $20.4 million secured its title because the 149th largest public firm in DFW. The annual record, compiled by Bloomberg for the Dallas Morning Information, examines public firms in a seventy-county space in North Texas, and ranks them by their whole income for the prior fiscal yr.
Christopher C. Reeg, Chief Govt Officer, commented, “We’re honored to have been named once more by the Dallas Morning Information as one of many prime 150 public firms in Dallas-Fort Value. It’s a privilege to work alongside a devoted and hardworking crew of staff, advisors, prospects, and strategic companions, with out whom this accomplishment wouldn’t be attainable. Even by these difficult occasions, we stay centered on our imaginative and prescient and can proceed to make the Dallas-Fort Value space proud by persevering with to develop and commercialize modern medical gadgets for the orthopedic market.”
To view the complete record of firms and extra info go to: Dallas Morning Information: The Searchable Information to Dallas-Fort Value’s 150 Largest Public Firms for 2022
About Fuse Medical, Inc.
Fuse is an rising producer and distributor of modern medical gadgets for the orthopedic and spine market. We offer a complete portfolio of merchandise within the orthopedic whole joints, sports activities drugs, trauma, foot and ankle area, in addition to, degenerative and deformity spine, osteobiologics, wound care, and regenerative merchandise. For extra details about the Firm, or for those who’re concerned with turning into a distributor of any Fuse’s merchandise, please contact us at email@example.com or go to: www.fusemedical.com.
Ahead Trying Statements
Sure statements on this press launch, represent “forward-looking statements” throughout the which means of the federal securities legal guidelines. Phrases similar to “might,” “may,” “will,” “ought to,” “imagine,” “count on,” “anticipate,” “estimate,” “proceed,” “predict,” “forecast,” “mission,” “plan,” “intend,” or related expressions or statements relating to intent, perception, or present expectations, are forward-looking statements. Whereas the Firm believes these forward-looking statements are affordable, undue reliance shouldn’t be positioned on any such forward-looking statements, that are primarily based solely on info out there to the Firm as of the date of this launch. These forward-looking statements are primarily based upon present estimates and assumptions and are topic to numerous dangers and uncertainties, together with, with out limitation, these set forth within the Firm’s filings with the Securities and Change Fee; the failure of the Firm to shut the transaction; and integration points with the consolidated firm. Thus, precise outcomes could possibly be materially totally different. The Firm expressly disclaims any obligation to replace or alter statements whether or not because of new info, future occasions, or in any other case, besides as required by regulation.
Fuse Medical, Inc.
Kenneth Walker, Investor Relations Analyst
Workplace (469) 862-3030
Facsimile (469) 862-3035